Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79811 |
DDR1/2 inhibitor-2
|
||
DDR1/2 inhibitor-2 (Example 31),作为一种DDR1/DDR2抑制剂,其IC50值小于100 nM,适用于癌症和纤维化疾病的研究领域。 | |||
T5402 |
DDR1-IN-2
DDR1 inhibitor 7rh |
Discoidin Domain Receptor (DDR) | Tyrosine Kinase/Adaptors |
DDR1-IN-2 (DDR1 inhibitor 7rh) 是盘状结构域受体 1 抑制剂 (IC50:13.1 nM),对 DDR2 的抑制作用相对较弱 (IC50:203 nM)。 | |||
T4646 |
TA-02
|
p38 MAPK; Autophagy | Autophagy; MAPK |
TA02 是一种Adezmapimod 类似物,是p38 MAPK 的抑制剂,其IC50值为 20 nM。它和Adezmapimod、SB 202190 具有相似的心源活性,可抑制 TGFBR-2。 | |||
T70201 |
S 16020-2
|
||
S 16020-2 is an olivacine derivative, and DNA topoisomerase II inhibitor endowed with a remarkable antitumor activity against various experimental tumors. | |||
T7862 |
VU6015929
|
Discoidin Domain Receptor (DDR) | Tyrosine Kinase/Adaptors |
VU6015929 是一种活性双盘状结构域受体 1/2 (DDR1/2) 的抑制剂(IC50 分别为 4.67 nM 和 7.39 nM)。 | |||
T60805 |
JNK3 inhibitor-2
|
||
JNK3 inhibitor-2 是一种有效的选择性JNK3抑制剂。JNK3 inhibitor-2 对 JNK1、JNK2、 JNK3的IC50值分别为 >100, >100, 0.25 μM。JNK3 inhibitor-2也抑制 DDR1 和 EGFR (T790M, L858R)。 | |||
T12925 |
Sitravatinib malate
MGCD516 malate,MG-516 malate |
TAM Receptor | Tyrosine Kinase/Adaptors |
Sitravatinib malate is an orally bioavailable receptor inhibitor of tyrosine kinase (RTK) (IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively.) , shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment. | |||
T15808 |
Merestinib dihydrochloride
LY2801653 dihydrochloride |
ROCK | Cell Cycle/Checkpoint; Cytoskeletal Signaling; Stem Cells |
Merestinib dihydrochloride is an effective and orally bioavailable c-Met inhibitor (Ki=2 nM). It has anti-tumor activities and also has potent activity against MST1R (IC50=11 nM), FLT3 (IC50=7 nM), AXL (IC50=2 nM), MERTK (IC50=10 nM), TEK (IC50=63 nM), RO |